Machine learning predicts dangerously low blood pressure during surgery

In March, the U.S. Food and Drug Administration granted a De Novo request to Edwards Lifesciences for its Acumen Hypotension Prediction Index software that uses the new algorithm. Cannesson is a consultant to the company.

“The Acumen Hypotension Prediction Index is a next-generation, predictive monitoring software that represents the future of how we can use patient data to improve healthcare,” said Catherine Szyman, corporate vice president of critical care at Edwards Lifesciences. “HPI improves patient care by providing intelligent decision support, moving beyond descriptive monitoring to facilitate predictive monitoring, which provides more clarity on a patient’s condition to enable clinicians to make more proactive decisions.”